<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01733940</url>
  </required_header>
  <id_info>
    <org_study_id>10/12</org_study_id>
    <nct_id>NCT01733940</nct_id>
  </id_info>
  <brief_title>Efficacy of Tegaderm-CHG® Dressing vs. Tegaderm-IV® Dressing</brief_title>
  <acronym>EAC-UCI</acronym>
  <official_title>Efficacy of Tegaderm-CHG® Dressing vs. Tegaderm-IV® Dressing in the Reduction of Central Catheter Colonization in Patients of the Intensive Care Unit of the University &quot;Gómez Ulla&quot; Hospital.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Central de la Defensa Gómez Ulla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Central de la Defensa Gómez Ulla</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: The vascular catheter-related bacteremia (BRC) is a major health problem in
      intensive care units. The use of dressings containing chlorhexidine gluconate (CHG) can
      decrease the catheters colonization, closely related to infection thereof.

      Objective: To determine the efficacy of the dressing &quot;Tegaderm CHG&quot; dressings versus
      &quot;Tegaderm IV&quot; dressings in reducing the risk of colonization of central intravascular
      catheters in the intensive care unit (ICU).

      Methods: Randomized controlled trial with blinding professional who reviews the main outcome.
      The study included patients over 18 years, indicating the central intravascular catheter
      implantation in the ICU or in the operating room, prior informed consent. Excluding subjects
      with positive blood culture at the time of catheter implantation.

      The estimated sample size is 398 patients, with a confidence level of 95% and a statistical
      power of 80%. The study protocol was approved by the ethics committee of the hospital.

      Be made prospectively followed subjects from study entry until catheter removal collecting
      information on age, sex, APACHEII, antibiotic therapy, duration of catheter insertion site
      and removal, reason for withdrawal and microbiological information.

      For statistical analysis, a model is adjusted multivariate logistic regression, determining
      the interaction of variables with the likelihood ratio test and confusion by switching
      between the crude and adjusted effect greater than 10%.

      Results and conclusions: The recruitment has started in November 2012 and is scheduled for
      completion in March 2013. This study will determine whether these new dressings are effective
      in our environment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of intravascular central catheter colonization.</measure>
    <time_frame>November 2012- March 2013</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse effects of CHG Tegaderm ® dressings.</measure>
    <time_frame>up to 4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">398</enrollment>
  <condition>Intravascular Catheter Colonization</condition>
  <arm_group>
    <arm_group_label>&quot;Tegaderm CHG&quot; Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm is receiving a clorhexidine dressing for intravascular catheters.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Tegaderm IV&quot; dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of tegaderm iv dressings for intravascular catheters. Change each 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Application of a dressing with clorhexidine gluconate in intravascular catheters.</intervention_name>
    <arm_group_label>&quot;Tegaderm CHG&quot; Dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Application of a dressing without clorhexidine gluconate</intervention_name>
    <arm_group_label>&quot;Tegaderm IV&quot; dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: over 18 years, indicating the central intravascular catheter
        implantation in the ICU or in the operating room, prior informed consent -

        Exclusion Criteria:positive blood culture at the time of catheter implantation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>ana isabel lopez figueras, MD</last_name>
    <phone>0034911586958</phone>
    <phone_ext>22958</phone_ext>
    <email>alopfi1@oc.mde.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Central Hospital of the Defense</name>
      <address>
        <city>Madrid</city>
        <zip>28047</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ana isabel lopez figueras</last_name>
      <email>alopfi1@oc.mde.es</email>
    </contact>
    <investigator>
      <last_name>Ana isabel López figueras</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2012</study_first_submitted>
  <study_first_submitted_qc>November 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2012</study_first_posted>
  <last_update_submitted>November 27, 2012</last_update_submitted>
  <last_update_submitted_qc>November 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Central de la Defensa Gómez Ulla</investigator_affiliation>
    <investigator_full_name>ANA ISABEL LÓPEZ FIGUERAS</investigator_full_name>
    <investigator_title>MD. Facultative of the Preventive Medicine Department</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

